Cargando…
Predicting survival of patients with spinal metastatic disease using PathFx 3.0 – A validation study of 668 patients in Sweden
INTRODUCTION: PathFx is a computer-based prediction model for estimating survival of patients with bone metastasis. The model has been validated in several studies, but this is the first validation using exclusively patients with spinal metastases. RESEARCH QUESTION: Is PathFx 3.0 a tool useful for...
Autores principales: | Carrwik, Christian, Tsagkozis, Panagiotis, Wedin, Rikard, Robinson, Yohan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729818/ https://www.ncbi.nlm.nih.gov/pubmed/36506283 http://dx.doi.org/10.1016/j.bas.2022.101669 |
Ejemplares similares
-
PathFX provides mechanistic insights into drug efficacy and safety for regulatory review and therapeutic development
por: Wilson, Jennifer L., et al.
Publicado: (2018) -
Can a Bayesian belief network for survival prediction in patients with extremity metastases (PATHFx) be externally validated in an Asian cohort of 356 surgically treated patients?
por: HSIEH, Hsiang-Chieh, et al.
Publicado: (2022) -
Prosthesis or osteosynthesis for the treatment of a pathological hip fracture? A nationwide registry-based cohort study
por: Tsagkozis, Panagiotis, et al.
Publicado: (2021) -
Survival after surgery for spinal metastatic disease: a nationwide multiregistry cohort study
por: Carrwik, Christian, et al.
Publicado: (2021) -
Does knowledge of the primary tumour affect survival after surgery for spinal metastatic disease? A retrospective longitudinal cohort study
por: Carrwik, Christian, et al.
Publicado: (2021)